Abstract CT018: TMPRSS2-ERG and RB1 as candidate predictive biomarkers for efficacy in TALAPRO-2: Phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Name: Work Video:
Duration: 3 min 30 s
Josep M. Piulats; Arun Azad; A. Douglas Laird; Nobuaki Matsubara; Karim Fizazi; Neal D. Shore; Lawrence I. Karsh; Glenn Liu; André P. Fay; Joan Carles; Robert J. Jones; Éric Voog; Stefanie Zschäbitz; Ugo De Giorgi; Steven Yip; Xinmeng Jasmine Mu; Xun Lin; Arne Engelsberg; Neeraj Agarwal
{'id': 'https://openalex.org/W4393988984', 'doi': 'https://doi.org/10.1158/1538-7445.am2024-ct018', 'title': 'Abstract CT018: TMPRSS2-ERG and RB1 as candidate predictive biomarkers for efficacy in TALAPRO-2: Phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)', 'display_name': 'Abstract CT018: TMPRSS2-ERG and RB1 as candidate predictive biomarkers for efficacy in TALAPRO-2: Phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)', 'publication_year': 2024, 'publication_date': '2024-04-05', 'ids': {'openalex': 'https://openalex.org/W4393988984', 'doi': 'https://doi.org/10.1158/1538-7445.am2024-ct018'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2024-ct018', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5019869973', 'display_name': 'Josep M. Piulats', 'orcid': 'https://orcid.org/0000-0002-3606-1724'}, 'institutions': [{'id': 'https://openalex.org/I4210087039', 'display_name': "Institut d'Investigació Biomédica de Bellvitge", 'ror': 'https://ror.org/0008xqs48', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I157913058', 'https://openalex.org/I2802050225', 'https://openalex.org/I4210087039', 'https://openalex.org/I4210096656', 'https://openalex.org/I4210106543', 'https://openalex.org/I4210107147', 'https://openalex.org/I4210153292', 'https://openalex.org/I4387153040', 'https://openalex.org/I71999127']}, {'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Josep M. Piulats', 'raw_affiliation_strings': ['1Institut Català d’Oncologia–Bellvitge Institute for Biomedical Research, Barcelona, Spain;'], 'affiliations': [{'raw_affiliation_string': '1Institut Català d’Oncologia–Bellvitge Institute for Biomedical Research, Barcelona, Spain;', 'institution_ids': ['https://openalex.org/I4210087039', 'https://openalex.org/I4210107147']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075093609', 'display_name': 'Arun Azad', 'orcid': 'https://orcid.org/0000-0001-7350-5622'}, 'institutions': [{'id': 'https://openalex.org/I2800555584', 'display_name': 'Peter MacCallum Cancer Centre', 'ror': 'https://ror.org/02a8bt934', 'country_code': 'AU', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800555584']}], 'countries': ['AU'], 'is_corresponding': False, 'raw_author_name': 'Arun A. Azad', 'raw_affiliation_strings': ['2Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;'], 'affiliations': [{'raw_affiliation_string': '2Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;', 'institution_ids': ['https://openalex.org/I2800555584']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087379820', 'display_name': 'A. Douglas Laird', 'orcid': 'https://orcid.org/0000-0002-7296-025X'}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A. Douglas Laird', 'raw_affiliation_strings': ['3Pfizer Inc., La Jolla, CA;'], 'affiliations': [{'raw_affiliation_string': '3Pfizer Inc., La Jolla, CA;', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014625956', 'display_name': 'Nobuaki Matsubara', 'orcid': 'https://orcid.org/0000-0002-9203-4245'}, 'institutions': [{'id': 'https://openalex.org/I4210145079', 'display_name': 'National Cancer Center Hospital East', 'ror': 'https://ror.org/03rm3gk43', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210145079']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Nobuaki Matsubara', 'raw_affiliation_strings': ['4National Cancer Center Hospital East, Chiba, Japan;'], 'affiliations': [{'raw_affiliation_string': '4National Cancer Center Hospital East, Chiba, Japan;', 'institution_ids': ['https://openalex.org/I4210145079']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007779528', 'display_name': 'Karim Fizazi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I277688954', 'display_name': 'Université Paris-Saclay', 'ror': 'https://ror.org/03xjwb503', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I277688954']}, {'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Karim Fizazi', 'raw_affiliation_strings': ['5Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France;'], 'affiliations': [{'raw_affiliation_string': '5Institut Gustave Roussy, University of Paris-Saclay, Villejuif, France;', 'institution_ids': ['https://openalex.org/I277688954', 'https://openalex.org/I2801843802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088518998', 'display_name': 'Neal D. Shore', 'orcid': 'https://orcid.org/0000-0001-5767-0548'}, 'institutions': [{'id': 'https://openalex.org/I4210165013', 'display_name': 'Carolina Urologic Research Center', 'ror': 'https://ror.org/05vk9vy20', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210165013']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Neal D. Shore', 'raw_affiliation_strings': ['6Carolina Urologic Research Center, Myrtle Beach, SC;'], 'affiliations': [{'raw_affiliation_string': '6Carolina Urologic Research Center, Myrtle Beach, SC;', 'institution_ids': ['https://openalex.org/I4210165013']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024685539', 'display_name': 'Lawrence I. Karsh', 'orcid': 'https://orcid.org/0000-0002-3095-8303'}, 'institutions': [{'id': 'https://openalex.org/I4210088091', 'display_name': 'The Urology Center of Colorado', 'ror': 'https://ror.org/0008nva35', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088091']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lawrence Karsh', 'raw_affiliation_strings': ['7The Urology Center of Colorado, Denver, CO;'], 'affiliations': [{'raw_affiliation_string': '7The Urology Center of Colorado, Denver, CO;', 'institution_ids': ['https://openalex.org/I4210088091']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030084075', 'display_name': 'Glenn Liu', 'orcid': 'https://orcid.org/0000-0002-9819-1911'}, 'institutions': [{'id': 'https://openalex.org/I4210103341', 'display_name': 'University of Wisconsin Carbone Cancer Center', 'ror': 'https://ror.org/01e4byj08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799905417', 'https://openalex.org/I4210103341', 'https://openalex.org/I4210132596']}, {'id': 'https://openalex.org/I135310074', 'display_name': 'University of Wisconsin–Madison', 'ror': 'https://ror.org/01y2jtd41', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I135310074']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Glenn Liu', 'raw_affiliation_strings': ['8Carbone Cancer Center, University of Wisconsin- Madison, Madison, WI;'], 'affiliations': [{'raw_affiliation_string': '8Carbone Cancer Center, University of Wisconsin- Madison, Madison, WI;', 'institution_ids': ['https://openalex.org/I4210103341', 'https://openalex.org/I135310074']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077071889', 'display_name': 'André P. Fay', 'orcid': 'https://orcid.org/0000-0002-8588-7012'}, 'institutions': [{'id': 'https://openalex.org/I45643870', 'display_name': 'Pontifícia Universidade Católica do Rio Grande do Sul', 'ror': 'https://ror.org/025vmq686', 'country_code': 'BR', 'type': 'education', 'lineage': ['https://openalex.org/I45643870']}], 'countries': ['BR'], 'is_corresponding': False, 'raw_author_name': 'Andre P. Fay', 'raw_affiliation_strings': ['9PUCRS School of Medicine, Porto Alegre, Brazil;'], 'affiliations': [{'raw_affiliation_string': '9PUCRS School of Medicine, Porto Alegre, Brazil;', 'institution_ids': ['https://openalex.org/I45643870']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001994148', 'display_name': 'Joan Carles', 'orcid': 'https://orcid.org/0000-0002-9983-5934'}, 'institutions': [{'id': 'https://openalex.org/I4387155398', 'display_name': "Vall d'Hebron Institute of Oncology", 'ror': 'https://ror.org/054xx3904', 'country_code': None, 'type': 'healthcare', 'lineage': ['https://openalex.org/I4387153040', 'https://openalex.org/I4387155398']}, {'id': 'https://openalex.org/I4210127641', 'display_name': "Vall d'Hebron Hospital Universitari", 'ror': 'https://ror.org/03ba28x55', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210127641']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Joan Carles', 'raw_affiliation_strings': ['10Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain;'], 'affiliations': [{'raw_affiliation_string': '10Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain;', 'institution_ids': ['https://openalex.org/I4387155398', 'https://openalex.org/I4210127641']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048796030', 'display_name': 'Robert J. Jones', 'orcid': 'https://orcid.org/0000-0002-2904-6980'}, 'institutions': [{'id': 'https://openalex.org/I2800373718', 'display_name': 'Beatson West of Scotland Cancer Centre', 'ror': 'https://ror.org/03pp86w19', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800373718']}, {'id': 'https://openalex.org/I7882870', 'display_name': 'University of Glasgow', 'ror': 'https://ror.org/00vtgdb53', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I7882870']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Robert J. Jones', 'raw_affiliation_strings': ['11School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;'], 'affiliations': [{'raw_affiliation_string': '11School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;', 'institution_ids': ['https://openalex.org/I2800373718', 'https://openalex.org/I7882870']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006671522', 'display_name': 'Éric Voog', 'orcid': 'https://orcid.org/0000-0001-8366-8003'}, 'institutions': [{'id': 'https://openalex.org/I4210123491', 'display_name': 'Centre Jean Bernard', 'ror': 'https://ror.org/02s2qzh96', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210123491']}, {'id': 'https://openalex.org/I4210135187', 'display_name': 'Clinique Victor Hugo', 'ror': 'https://ror.org/04qvenw96', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210135187']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Eric Voog', 'raw_affiliation_strings': ['12Clinique Victor Hugo Centre Jean Bernard, Le Mans, France;'], 'affiliations': [{'raw_affiliation_string': '12Clinique Victor Hugo Centre Jean Bernard, Le Mans, France;', 'institution_ids': ['https://openalex.org/I4210123491', 'https://openalex.org/I4210135187']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032459418', 'display_name': 'Stefanie Zschäbitz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210111460', 'display_name': 'National Center for Tumor Diseases', 'ror': 'https://ror.org/01txwsw02', 'country_code': 'DE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210111460']}, {'id': 'https://openalex.org/I223822909', 'display_name': 'Heidelberg University', 'ror': 'https://ror.org/038t36y30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I223822909']}, {'id': 'https://openalex.org/I2802164966', 'display_name': 'University Hospital Heidelberg', 'ror': 'https://ror.org/013czdx64', 'country_code': 'DE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802164966']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Stefanie Zschäbitz', 'raw_affiliation_strings': ['13National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany;'], 'affiliations': [{'raw_affiliation_string': '13National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany;', 'institution_ids': ['https://openalex.org/I4210111460', 'https://openalex.org/I223822909', 'https://openalex.org/I2802164966']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071060598', 'display_name': 'Ugo De Giorgi', 'orcid': 'https://orcid.org/0000-0001-7520-2908'}, 'institutions': [{'id': 'https://openalex.org/I4210097834', 'display_name': 'Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori', 'ror': 'https://ror.org/013wkc921', 'country_code': 'IT', 'type': 'facility', 'lineage': ['https://openalex.org/I4210097834', 'https://openalex.org/I4210153126']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Ugo De Giorgi', 'raw_affiliation_strings': ['14IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy;'], 'affiliations': [{'raw_affiliation_string': '14IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy;', 'institution_ids': ['https://openalex.org/I4210097834']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023028363', 'display_name': 'Steven Yip', 'orcid': 'https://orcid.org/0000-0003-2802-6651'}, 'institutions': [{'id': 'https://openalex.org/I4210160908', 'display_name': 'Baker Hughes (Canada)', 'ror': 'https://ror.org/05vpf1q78', 'country_code': 'CA', 'type': 'company', 'lineage': ['https://openalex.org/I257179599', 'https://openalex.org/I4210160908']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Steven M. Yip', 'raw_affiliation_strings': ['15Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, Alberta, Canada;'], 'affiliations': [{'raw_affiliation_string': '15Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, Alberta, Canada;', 'institution_ids': ['https://openalex.org/I4210160908']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037451699', 'display_name': 'Xinmeng Jasmine Mu', 'orcid': 'https://orcid.org/0000-0002-8079-0828'}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Xinmeng Jasmine Mu', 'raw_affiliation_strings': ['3Pfizer Inc., La Jolla, CA;'], 'affiliations': [{'raw_affiliation_string': '3Pfizer Inc., La Jolla, CA;', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103089450', 'display_name': 'Xun Lin', 'orcid': 'https://orcid.org/0000-0001-9882-0223'}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Xun Lin', 'raw_affiliation_strings': ['3Pfizer Inc., La Jolla, CA;'], 'affiliations': [{'raw_affiliation_string': '3Pfizer Inc., La Jolla, CA;', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003309897', 'display_name': 'Arne Engelsberg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100293', 'display_name': 'Pfizer (Germany)', 'ror': 'https://ror.org/00m8w3m39', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I4210100293']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Arne Engelsberg', 'raw_affiliation_strings': ['16Pfizer Pharma GmbH, Berlin, Germany;'], 'affiliations': [{'raw_affiliation_string': '16Pfizer Pharma GmbH, Berlin, Germany;', 'institution_ids': ['https://openalex.org/I4210100293']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5100763587', 'display_name': 'Neeraj Agarwal', 'orcid': 'https://orcid.org/0000-0003-1076-0428'}, 'institutions': [{'id': 'https://openalex.org/I2801159745', 'display_name': 'Huntsman Cancer Institute', 'ror': 'https://ror.org/03v7tx966', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801159745', 'https://openalex.org/I4210148268']}, {'id': 'https://openalex.org/I223532165', 'display_name': 'University of Utah', 'ror': 'https://ror.org/03r0ha626', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I223532165']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Neeraj Agarwal', 'raw_affiliation_strings': ['17Huntsman Cancer Institute (NCI-CCC), University of Utah, Salt Lake City, UT.'], 'affiliations': [{'raw_affiliation_string': '17Huntsman Cancer Institute (NCI-CCC), University of Utah, Salt Lake City, UT.', 'institution_ids': ['https://openalex.org/I2801159745', 'https://openalex.org/I223532165']}]}], 'institution_assertions': [], 'countries_distinct_count': 10, 'institutions_distinct_count': 26, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 3.146, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.999956, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '84', 'issue': '7_Supplement', 'first_page': 'CT018', 'last_page': 'CT018'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.7715093}, {'id': 'https://openalex.org/keywords/tmprss2', 'display_name': 'TMPRSS2', 'score': 0.4960421}, {'id': 'https://openalex.org/keywords/erg', 'display_name': 'Erg', 'score': 0.42568755}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.7715093}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.55597746}, {'id': 'https://openalex.org/C2778042024', 'wikidata': 'https://www.wikidata.org/wiki/Q18032025', 'display_name': 'TMPRSS2', 'level': 5, 'score': 0.4960421}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.46353507}, {'id': 'https://openalex.org/C103796816', 'wikidata': 'https://www.wikidata.org/wiki/Q185153', 'display_name': 'Erg', 'level': 3, 'score': 0.42568755}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.40804088}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.39168814}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.2890549}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.28107557}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.123925686}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.10512516}, {'id': 'https://openalex.org/C118487528', 'wikidata': 'https://www.wikidata.org/wiki/Q161437', 'display_name': 'Ophthalmology', 'level': 1, 'score': 0.10476506}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.05542329}, {'id': 'https://openalex.org/C3008058167', 'wikidata': 'https://www.wikidata.org/wiki/Q84263196', 'display_name': 'Coronavirus disease 2019 (COVID-19)', 'level': 4, 'score': 0.05332926}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.04795748}, {'id': 'https://openalex.org/C2780827179', 'wikidata': 'https://www.wikidata.org/wiki/Q422001', 'display_name': 'Retinal', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C524204448', 'wikidata': 'https://www.wikidata.org/wiki/Q788926', 'display_name': 'Infectious disease (medical specialty)', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2024-ct018', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4361257438', 'https://openalex.org/W4361257326', 'https://openalex.org/W3114959685', 'https://openalex.org/W2734972278', 'https://openalex.org/W2466731562', 'https://openalex.org/W2169428763', 'https://openalex.org/W2017225094', 'https://openalex.org/W1982109854', 'https://openalex.org/W1961441859', 'https://openalex.org/W1553651930'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'In': [2, 114, 171], 'TALAPRO-2': [3, 76], '(NCT03395197),': [4], 'pts': [5, 56, 95, 110, 134, 147, 172, 208], 'unselected': [6], 'for': [7, 255, 524, 562], 'homologous': [8], 'recombination': [9], 'repair': [10], '(HRR)': [11], 'gene': [12, 44, 60, 64, 102, 106, 175, 180, 245, 289, 293, 298], 'mutations': [13], '(muts)': [14], 'received': [15], 'TALA': [16, 26, 51, 118, 128, 183, 198, 224, 259, 314, 322, 394, 402], '+': [17, 21, 27, 52, 119, 125, 129, 184, 192, 199, 203, 225, 232, 260, 264, 315, 319, 323, 327, 395, 399, 403, 407, 534, 540], 'ENZA': [18, 22, 28, 53, 120, 126, 130, 185, 200, 204, 226, 233, 261, 285, 316, 320, 324, 328, 396, 400, 404, 408, 541], 'or': [19, 138, 150, 212], 'PBO': [20, 124, 191, 202, 231, 263, 318, 326, 398, 406], 'in': [23, 55, 96, 133, 146, 188, 207, 234, 238, 526, 546], '1L': [24], 'mCRPC.': [25], 'significantly': [29], 'improved': [30, 121, 131, 227], 'radiographic': [31], 'progression-free': [32], 'survival': [33], '(rPFS).': [34], 'Previous': [35], 'analyses': [36], 'focused': [37], 'on': [38], 'the': [39, 97, 559], 'association': [40, 159], 'of': [41, 74, 78, 160, 243, 277, 531, 558], 'tumor': [42], 'HRR': [43, 63, 105, 179, 244, 297], 'muts': [45, 103, 152, 176, 181, 237, 290, 294, 299], 'with': [46, 57, 135, 148, 162, 173, 197, 209, 230, 236, 274, 295, 549], 'outcome;': [47], 'here,': [48], 'we': [49], 'examined': [50], 'efficacy': [54, 257, 525], '≥1': [58, 287, 291], 'non-HRR': [59, 101, 174, 240, 288, 292, 331], 'mut': [61], 'with/without': [62, 104], 'muts.': [65], 'Methods:': [66], 'This': [67], 'is': [68], 'a': [69, 75, 270], 'post-hoc': [70], 'exploratory': [71], 'agnostic': [72], 'analysis': [73], 'dataset': [77], 'prospectively': [79], 'collected/retrospectively': [80], 'analyzed': [81], 'plasma': [82], 'ctDNA': [83], '(FoundationOne®Liquid': [84], 'CDx).': [85], 'Response': [86], 'was': [87, 165, 205], 'assessed': [88], 'per': [89], 'RECIST': [90], 'v1.1.': [91], 'Results:': [92], 'Overall,': [93], '616': [94, 116], 'intent-to-treat': [98], 'population': [99], 'had': [100, 111], 'muts;': [107], '98': [108], '(16%)': [109], 'TMPRSS2-ERG': [112, 149, 216, 247, 410, 517], 'fusions.': [113], 'these': [115], 'pts,': [117], 'rPFS': [122, 132, 164, 189, 195], 'vs': [123, 190, 201, 262, 537], '(Table).': [127], 'TMPRSS2-ERG,': [136, 168, 210, 340], 'RB1,': [137, 211, 368], 'MLL2': [139, 161, 213, 423], 'muts,': [140, 214], 'and': [141, 153, 177, 248, 281, 518, 573], 'objective': [142], 'response': [143], 'rates': [144], '(ORR)': [145], 'RB1': [151, 249, 433, 519], 'measurable': [154], 'disease': [155, 465], 'at': [156, 466], 'baseline': [157, 467], '(the': [158], 'enhanced': [163], 'lost': [166], 'without': [167], 'not': [169, 452, 459], 'shown).': [170], 'no': [178, 296], '(n=427),': [182], 'showed': [186], 'improvement': [187], 'ENZA.': [193, 265], 'Enhanced': [194], 'benefit': [196], 'noted': [206], 'but': [215], 'ORRs': [217], 'were': [218], 'similar': [219], 'across': [220], 'treatment': [221, 545], 'arms.': [222], 'Conclusions:': [223], 'outcomes': [228], 'compared': [229], 'patients': [235, 547], 'specific': [239], 'genes': [241], '(regardless': [242], 'muts).': [246], 'emerged': [250], 'as': [251, 520, 542], 'candidate': [252, 521], 'predictive': [253, 522], 'biomarkers': [254, 523], 'differential': [256], 'favoring': [258], 'PARP': [266], 'inhibitors': [267], 'may': [268], 'induce': [269], 'synthetically': [271], 'lethal': [272], 'interaction': [273], 'TMPRSS2-ERG-mediated': [275], 'inhibition': [276], 'non-homologous': [278], 'end': [279], 'joining': [280], 'help': [282], 'overcome': [283], 'RB1-mediated': [284], 'resistance.': [286], 'Median': [300, 306], 'rPFS,': [301, 307], 'mo': [302, 308], 'HR': [303, 309], '(95%': [304, 310, 386, 392], 'CI)': [305, 311, 387, 393], 'Gene': [312], 'mutation': [313], '(N=310)': [317], '(N=306)': [321], '(N=218)': [325], '(N=209)': [329], 'Any': [330], 'NR': [332, 336, 362], '19.3': [333], '0.63': [334], '(0.50–0.80)': [335], '22.5': [337], '0.66': [338], '(0.49–0.89)': [339], '[n]': [341, 355, 369], '25.9': [342], '[n=43]': [343], '11.0': [344, 350], '[n=55]': [345], '0.36': [346], '(0.20–0.64)': [347], '19.4': [348], '[n=32]': [349], '[n=44]': [351], '0.40': [352, 380], '(0.20–0.76)': [353], 'MLL2,': [354], '18.2': [356], '[n=20]': [357, 359], '13.8': [358], '0.43': [360], '(0.19–0.98)': [361], '[n=8]': [363, 373], '17.2': [364], '[n=11]': [365], '0.50': [366], '(0.14–1.74)': [367], '9.8': [370], '[n=14]': [371], '1.9': [372], '0.22': [374], '(0.07–0.73)': [375], '10.8': [376], '[n=6]': [377], '1.8': [378], '[n=3]': [379], '(0.05–2.92)': [381], 'ORR,': [382, 388], '%': [383, 389], '(n/N)a': [384, 390], 'OR': [385, 391], '(N=96)': [397], '(N=105)': [401], '(N=62)': [405], '(N=75)': [409], '56': [411], '(13/23)': [412], '41': [413], '(7/17)': [414], '0.54': [415], '(0.12–2.27)': [416], '53': [417], '(9/17)': [418], '47': [419], '(7/15)': [420], '0.78': [421], '(0.16–3.85)': [422], '64': [424], '(7/11)': [425], '70': [426], '(7/10)': [427], '1.33': [428], '(0.15–12.60)': [429], 'ND': [430, 431, 432, 440, 441, 442], '62': [434], '(5/8)': [435], '0': [436], '(0/6)': [437], '0.00': [438], '(0.00–0.75)': [439], 'CI,': [443], 'confidence': [444], 'interval;': [445], 'HR,': [446], 'hazard': [447], 'ratio;': [448], 'mo,': [449], 'months;': [450], 'ND,': [451], 'displayed': [453], '(combined': [454], 'prevalence': [455], '&amp;lt;10': [456], 'pts);': [457], 'NR,': [458], 'reached;': [460], 'OR,': [461], 'odds': [462], 'ratio.': [463], 'aMeasurable': [464], 'Citation': [468], 'Format:': [469], 'Josep': [470], 'M.': [471, 506], 'Piulats,': [472], 'Arun': [473], 'A.': [474, 476], 'Azad,': [475], 'Douglas': [477], 'Laird,': [478], 'Nobuaki': [479], 'Matsubara,': [480], 'Karim': [481], 'Fizazi,': [482], 'Neal': [483], 'D.': [484], 'Shore,': [485], 'Lawrence': [486], 'Karsh,': [487], 'Glenn': [488], 'Liu,': [489], 'Andre': [490], 'P.': [491], 'Fay,': [492], 'Joan': [493], 'Carles,': [494], 'Robert': [495], 'J.': [496], 'Jones,': [497], 'Eric': [498], 'Voog,': [499], 'Stefanie': [500], 'Zschäbitz,': [501], 'Ugo': [502], 'De': [503], 'Giorgi,': [504], 'Steven': [505], 'Yip,': [507], 'Xinmeng': [508], 'Jasmine': [509], 'Mu,': [510], 'Xun': [511], 'Lin,': [512], 'Arne': [513], 'Engelsberg,': [514], 'Neeraj': [515], 'Agarwal.': [516], 'TALAPRO-2:': [527], 'Phase': [528], '3': [529], 'study': [530], 'talazoparib': [532], '(TALA)': [533], 'enzalutamide': [535], '(ENZA)': [536], 'placebo': [538], '(PBO)': [539], 'first-line': [543], '(1L)': [544], '(pts)': [548], 'metastatic': [550], 'castration-resistant': [551], 'prostate': [552], 'cancer': [553], '(mCRPC)': [554], '[abstract].': [555], 'In:': [556], 'Proceedings': [557], 'American': [560], 'Association': [561], 'Cancer': [563, 585], 'Research': [564], 'Annual': [565], 'Meeting': [566], '2024;': [567], 'Part': [568], '2': [569], '(Late-Breaking,': [570], 'Clinical': [571], 'Trial,': [572], 'Invited': [574], 'Abstracts);': [575], '2024': [576], 'Apr': [577], '5-10;': [578], 'San': [579], 'Diego,': [580], 'CA.': [581], 'Philadelphia': [582], '(PA):': [583], 'AACR;': [584], 'Res': [586], '2024;84(7_Suppl):Abstract': [587], 'nr': [588], 'CT018.': [589]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4393988984', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}], 'updated_date': '2025-01-12T08:32:19.718350', 'created_date': '2024-04-06'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
